Kim Ho Jin, Oh You Na, Ju Min Ho, Kim Joon Bum, Jung Sung-Ho, Chung Cheol Hyun, Lee Jae Won, Choo Suk Jung
Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
J Thorac Dis. 2018 May;10(5):2656-2665. doi: 10.21037/jtd.2018.05.14.
We reviewed our experience with on-pump beating (OPB) heart coronary artery bypass grafting (CABG) to evaluate the impacts of obviating aortic cross-clamping and cardioplegic arrest on clinical outcomes compared with conventional CABG (C-CABG).
Between 2006 and 2012, elective isolated cardiopulmonary bypass (CPB)-assisted CABG was consecutively performed in 645 patients (mean patient age 63.3±9.1 years, 471 women) with 254 (39.4%) undergoing OPB-CABG and 391 (60.6%) undergoing C-CABG. The early and long-term clinical outcomes were compared between the two groups after adjusting for risk profiles through propensity score (PS) analyses.
The OPB-CABG group presented significant morbidities more frequently than the C-CABG group, including severe chronic kidney disease (CKD) (P=0.026), severe chest pain (P<0.001), and poor left ventricular function (P<0.001). Early mortality occurred in 6 (2.4%) and 2 (0.5%) patients in the OPB- and C-CABG group, respectively (P=0.087). The number of distal anastomosis was comparable between the two groups (3.0±0.9 3.0±1.0, P=0.816). After PS matching, the incidence of major complications such as stroke (P>0.99) and new-onset dialysis (P=0.109) was comparable. During a median follow-up of 81.0 months (quartiles 1-3, 66.6-95.0 months), 118 patients died and the PS-matched models showed no significant between-group differences in the risk of overall death [hazard ratio (HR), 1.19; 95% confidence interval (CI), 0.72-1.95; P=0.507] and major adverse cardiac events (MACE) (HR, 1.49; 95% CI, 0.67-3.31; P=0.328).
The OPB strategy may be as safe and effective as the conventional strategy during CABG among patients with similar risk profiles. A prospective randomized trial is warranted to better ascertain the beneficial impact of OPB-CABG as both a viable and a durable alternative strategy to C-CABG.
我们回顾了心脏不停跳冠状动脉搭桥术(OPB-CABG)的经验,以评估与传统冠状动脉搭桥术(C-CABG)相比,避免主动脉阻断和心脏停搏对临床结局的影响。
2006年至2012年期间,645例患者(平均年龄63.3±9.1岁,女性471例)连续接受了择期体外循环(CPB)辅助下的冠状动脉搭桥术,其中254例(39.4%)接受OPB-CABG,391例(60.6%)接受C-CABG。通过倾向评分(PS)分析调整风险特征后,比较两组的早期和长期临床结局。
OPB-CABG组比C-CABG组更频繁地出现严重并发症,包括严重慢性肾病(CKD)(P=0.026)、严重胸痛(P<0.001)和左心室功能不全(P<0.001)。OPB-CABG组和C-CABG组分别有6例(2.4%)和2例(0.5%)患者发生早期死亡(P=0.087)。两组的远端吻合数量相当(3.0±0.9对3.0±1.0,P=0.816)。PS匹配后,中风(P>0.99)和新发透析(P=0.109)等主要并发症的发生率相当。在中位随访81.0个月(四分位数1-3,66.6-95.0个月)期间,118例患者死亡,PS匹配模型显示两组在全因死亡风险[风险比(HR),1.19;95%置信区间(CI),0.72-1.95;P=0.507]和主要不良心脏事件(MACE)(HR,1.49;95%CI,0.67-3.31;P=0.328)方面无显著组间差异。
在具有相似风险特征的患者中,OPB策略在冠状动脉搭桥术中可能与传统策略一样安全有效。有必要进行一项前瞻性随机试验,以更好地确定OPB-CABG作为C-CABG一种可行且持久的替代策略的有益影响。